Toripalimab in advanced biliary tract cancerWei Li, Tianshu Liu, Yueqi Wang et al.|The Innovation|2022Cited by 21
Toripalimab combined with gemcitabine and S-1 in the first-line treatment of advanced biliary tract cancer.Wei Li, Tianshu Liu, Yueqi Wang et al.|Journal of Clinical Oncology|2022Cited by 3
Innate–adaptive IFN cross-talk reprograms myeloid and T cells for antitumor immunity with a second-generation recombinant MVAShuaitong Liu, Liang Deng, Wei Yan et al.|bioRxiv (Cold Spring Harbor Laboratory)|2022Cited by 1
Abstract 3280: Type I IFN receptor signaling in myeloid and T cells drives antitumor immunity elicited by intratumoral delivery of immunogenic recombinant modified vaccinia virus AnkaraYueqi Wang, Liang Deng, Shanza Baseer Tariq et al.|Cancer Research|2025Cited by 0
890 Intravesical recombinant MVA therapy induces local and systemic antitumor immunity and memory in an orthotopic murine bladder cancer modelJuan Carlos Angulo-Lozano, Liang Deng, Yueqi Wang et al.|Regular and Young Investigator Award Abstracts|2025Cited by 0